Logo-bi
Review

1. Unlocking the potential of lumateperone and novel anti-psychotics for schizophrenia
S Rehan Ahmad* ORCID, Md Zeyaullah* ORCID, Abdullah M. AlShahrani, Mohammad Suhail Khan, Adam Dawria, Ali Mohieldin, Haroon Ali, Abdelrhman AG Altijani, Mohammad Shane Alam, Munzila Mehdi, Sabika Akram, Ejaz Rizvi Hussain, Mohammad Amjad Kamal
Bioimpacts. 2025;15: 30259 | Published on: 2024 Sep 09. doi: 10.34172/bi.30259
PMCID: PMC11954750     PMID: 40161932     Scopus ID: 85217952339    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
0
0
0
Original Article

2. A potential mechanism for tau protein modulating in schizophrenia with transcranial direct current stimulation intervention: A randomized controlled trial
Ali Reza Shafiee-Kandjani ORCID, Farnaz Chalabianloo* ORCID, Sara Farhang ORCID, Dariush Shanehbandi ORCID, Behzad Shalchi ORCID
Bioimpacts. 2025;15: 30274 | Published on: 2024 Jul 22. doi: 10.34172/bi.30274
PMCID: PMC11954739     PMID: 40161936     Scopus ID: 85215667000    
Article
PDF
Full Text
XML
Cited By:
0
0
0
Original Article

3. Exploring the potential of tubulin-associated unit protein as a biomarker for schizophrenia
Ali Reza Shafiee-Kandjani ORCID, Ali Bazzaz Haghighat Talab, Sara Farhang, Dariush Shanehbandi, Milad Asadi, Ailar Nakhlband* ORCID
Bioimpacts. 2025;15: 30813 | Published on: 2025 Dec 07. doi: 10.34172/bi.30813
Article
PDF
XML
Cited By:
0
0
0

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons